QUOTE AND NEWS
PR Newswire  Nov 18  Comment 
LOS ANGELES, Nov. 18 /PRNewswire-FirstCall/ -- GTX Corp (OTC Bulletin Board: GTXO), (www.gtxcorp.com), a leader in embedded GPS real-time Personal Location Services (PLS), has entered into an agreement with Dutchess Opportunity Fund, II, LP, who will
Business Wire  Nov 11  Comment 
GTx, Inc. (NASDAQ: GTXI), announced today that management will present a company overview on November 17 at the Lazard Capital Markets 6th Annual Healthcare Conference in New York City. The GTx presentation will begin at 4:10 p.m. Eastern Time. A
Canadian Business  Nov 9  Comment 
Among the earnings stories for Monday, Nov. 9, from AP Financial News:Biotechnology company GTx Inc. said Monday its third-quarter loss
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/GTx+%28GTXI%29+Posts+Q3+Loss+of+35c%2C+In-Line+with+Estimates/5086686.html for the full story.
Business Wire  Nov 9  Comment 
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9
Business Wire  Nov 4  Comment 
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to discuss the Company’s third quarter 2009 corporate results on Monday, November 9 at 9:00 a.m. Eastern. The call and webcast will follow the release of the
TheStreet.com  Nov 2  Comment 
Steiner claims FDA 'moved the goalposts" during acapodene review.
Business Wire  Nov 2  Comment 
GTx, Inc. (NASDAQ: GTXI) today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with
Business Wire  Oct 30  Comment 
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast on Monday, November 2, 2009 to provide an update regarding the New Drug Application for toremifene 80 mg to reduce fractures in men with prostate cancer on
TheStreet.com  Oct 27  Comment 
Acapodene faces an FDA decision Friday.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


You may also be interested in articles related to GTx (GTXI):
 
GTXI AT A GLANCE
P/E -2.60 
EV/EBITDA -6.85 
ROA -54.4%AVG
ROE -220.8%AVG
Debt to Equity 3KVERY HIGH
Current Ratio 3.13AVG
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki